Home › Products › Cardiology › Verquvo 2.5mg Tablet
Verquvo 2.5mg Tablet
Salt Composition: VERICIGUAT
- Manufacturer: BAYER ZYDUS PHARMA PVT LTD
- Pack Size: 14 TABLET(s) IN A STRIP
- Dosage Form: TABLET
- Strength: 2.5MG
- Prescription Required
- Storage: Store verquvo tablet 2.5 mg at 20 to 25°C Protect the medicine from light and excessive moisture. Keep the medicine out of reach of children and pets If you forgot to take the tablet, take it as soon as you remember. However, skip the missed dose if it is nearly time for the next dose.
₹1518.00₹1785.90
Inclusive of all taxes
Product Introduction
Verquvo 2.5mg tablet contains the active substance vericiguat. It is a cardiovascular agent that belongs to the class of medications called soluble guanylate cyclase stimulators. It is used to reduce the risk of death and the need for hospitalisation in certain adults with heart failure. Heart failure occurs when your heart is weak and cannot pump enough blood to your body. Common symptoms of heart failure are shortness of breath, tiredness, or swelling caused by fluid build-up. Do not take Verquvo 2.5mg if you are allergic to vericiguat or any of the other ingredients of this medicine. Inform your physician if you have low blood pressure with symptoms like dizziness or light-headedness, severe liver or kidney problems, and if you are on dialysis. This medicine is not recommended for children and adolescents under 18 years. Tell your doctor if you are pregnant or breastfeeding before starting treatment. Verquvo 2.5mg substitute options should only be considered under the guidance of a healthcare professional to ensure safe and effective treatment for heart failure. Do not stop taking this medicine without informing your doctor because it may worsen your condition. The most common side effects of Verquvo 2.5mg are low blood pressure and anaemia. Use effective contraception during treatment and one month after your last dose. If you cannot swallow the tablet whole, it may be crushed and mixed with food immediately before administration.
Uses
Verquvo 2.5 mg Tablet uses are: To reduce the risk of death and hospitalization in adults with heart failure
How it works
Verquvo 2.5mg tablet is a soluble guanylate cyclase stimulator (an important enzyme in the nitric oxide signaling pathway). Heart failure is associated with impaired synthesis of nitric oxide and decreased activity of this enzyme, which may contribute to myocardial and vascular dysfunction. This medicine works by relaxing the blood vessels in the lungs to allow blood to flow easily.
How to Use
Always use this medicine as exactly prescribed by your doctor. Depending on the condition being treated, your physician decides the dose, dosage, and duration of the treatment. Take the tablet at the same time every day with food. If you cannot swallow the tablet, you can crush it and mix it with water. Take the mixture immediately.
Side Effects
Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them. Verquvo 2.5 mg side effects are: Common Low blood pressure (Hypotension) Anemia
Expert Tips
Take a dose as soon as you remember. If it is almost time for your next dose, wait until then and take a regular dose. Do not take extra medicine to make up for a missed dose. It is not safe to take this medicine during pregnancy. It could harm an unborn baby. Tell your doctor right away if you become pregnant. Inform your doctor if you notice any unusual bleeding or bruising. Your doctor may suggest you to take certain tests to monitor the effectiveness and side effects of the therapy.
References
- Verquvo 10 mg film-coated tablets - Patient Information Leaflet (PIL) - (emc). www.medicines.org.uk. [revised 2021] [cited 2023 Jun 3]. Available from: https://www.medicines.org.uk/emc/product/12775/pil
- Merk&Co., Vericiguat film-coated tablets. Access.fda.gov. [revised 2021 Jan] [cited 2023 Jun 3]. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/214377s000lbl.pdf
- Armstrong PW, Pieske B, Anstrom KJ, Ezekowitz J, Hernandez AF, Butler J, et al. Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction. New England Journal of Medicine. [Published 2020 May 14] [cited 2023 Jun 3];382(20):1883â93. Available from: https://pubmed.ncbi.nlm.nih.gov/32222134/
Safety Advice
Pregnancy: unsafe Do not use Verquvo 2.5mg tablet during pregnancy because it is not known if it harms the unborn baby. Inform your physician if you are pregnant, suspecting pregnancy, or planning to get pregnant during the treatment. Use effective contraception during the treatment and for one month after the last dose.
Lungs: Consult your doctor It is not known whether Verquvo 2.5mg tablet can be used in patients with lung disorders. Consult your doctor if you have any lung diseases before starting the treatment.
Breastfeeding: unsafe Breastfeeding is not recommended in patients taking Verquvo 2.5mg tablet because the medicine passes into the breast milk in small amounts and may harm your baby. Do not breastfeed during the treatment.
Disclaimer
The information provided on this page is intended for general informational purposes only and should not be considered as medical advice. Always consult a qualified healthcare professional before starting, stopping, or changing any medication. Self-medication can be harmful. Med For Rare does not endorse self-diagnosis or self-treatment.